Skip to content

PSYC

Clarify Pharma PLC

Access


ISIN

GB00BMCD8M81

Bid

0.42

Mid

0.435

Ask

0.45

Key Information

Price Change
0.00%
Year High
0.81
Year Low
0.435
Last Trade
17 Nov 23
Market Cap
£1.29M
Par
0.001
Bid
0.42
Mid Price
0.435
Ask
0.45
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
297.2M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About Clarify Pharma PLC

Clarify seeks to develop a business concentrating on high potential and fast-growing biotech and life science companies that perform research or produce neuro-pharmaceutical drug development platforms. The focus will be on businesses that advance medicines based on psychedelic substances through rigorous science and clinical trials.

Clarify Pharma PLCAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

17 Nov 23

16:41

120,0000.40480.00

17 Nov 23

12:11

120,0000.45540.00

13 Nov 23

08:47

2,500,0000.133,250.00

10 Oct 23

08:53

250,0000.521,300.00

09 Oct 23

14:21

120,0000.53636.00
View all trades

Latest Announcements & Notices

DateTitle

31 Aug 23

17:02

Clarify Pharma PLC - Interim Results

05 Jul 23

12:20

Clarify Pharma PLC - Results of Annual General Meeting

13 Jun 23

15:51

Clarify Pharma PLC - Notice of Annual General Meeting

30 May 23

07:00

Clarify Pharma PLC - Full Year Results

-
View all announcements

Address

Registered Address

9th Floor, 16 Great Queen Street, London, WC2B 5DG, England

Email

info@first-sentinel.com

Phone

+44 (0) 203 989 2222

Contacts

Corporate Adviser

First Sentinel Corporate Finance, 72 Charlotte Street, London , W1T 4QQ, United Kingdom

Registrar

Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS13 8AE, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal